• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    LOTTE BIOLOGICS

    Societal CDMO

    Federal Equipment Company

    INCOG BioPharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    LOTTE BIOLOGICS

    Societal CDMO

    Federal Equipment Company

    INCOG BioPharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    CPI Expands Continuous Manufacturing Partner Network

    Siemens, Perceptive Engineering and PSE become partners in the Medicines Manufacturing Innovation Center to advance continuous manufacturing.

    CPI Expands Continuous Manufacturing Partner Network
    Artist's rendition of the Medicines Manufacturing Innovation Center.
    Contract Pharma Staff08.28.20
    CPI has signed partnership agreements with Siemens plc, Perceptive Engineering LTD and Process Systems Enterprise LTD (PSE), making them a part of the Medicines Manufacturing Innovation Center collaboration. The partnership agreements will help strengthen the UK’s position as a global leader in pharmaceutical manufacturing through the development of continuous manufacturing innovations. Each partner will contribute to the development of a digital manufacturing solution, which will help the pharmaceutical industry as it moves towards smaller batches of more personalized medicines that require faster and more efficient manufacture.
     
    Siemens is a global leader in process automation and will provide both hardware and software to enhance the control of pharmaceutical manufacturing processes. The application of Siemens’ leading-edge digitalization technologies will connect the physical and digital worlds and provide the real-time information necessary for rapid decision making in a secure manner.
     
    Innovation partner Perceptive Engineering will utilize its fully integrated software platform, PharmaMV, to enable the generation of Advanced Process Control models for optimized continuous manufacturing. Rather than simply reacting to a set of data points for in-process control, the PharmaMV platform adapts manufacturing process parameters in response to predictions, ensuring tighter manufacturing specifications can be achieved and quality information is generated in real-time. These approaches also enable the future application of technologies such as Machine Learning and Artificial Intelligence to pharmaceutical processing. 
     
    PSE is the leading supplier of Advanced Process Modelling (APM) software and will utilize predictive process modelling to increase R&D efficiency, reduce tech transfer risk, and develop more robust control strategies. Through use of mechanistic models for continuous drug manufacture in PSE’s gPROMS FormulatedProducts platform, the industry is able to move away from a design-make-test cycle and toward a ‘predict first’ model (i.e. design, test, make). By reordering the R&D paradigm, more design activities can be undertaken before committing material, which will result in fast, sustainable and cost-effective manufacturing process development.
     
    By connecting real-time information, data modelling and Advanced Process Control, we will be able to forge a clear pathway to faster, cheaper and more sustainable continuous medicines manufacturing.
     
    The Medicines Manufacturing Innovation Center is a collaboration between CPI, the University of Strathclyde and founding industry partners, GSK and AstraZeneca with funding provided by Scottish Enterprise and UK Research and Innovation. The partnership agreements will help the Medicines Manufacturing Innovation Centre achieve its flagship Grand Challenge projects. Bringing together three technologies for advancing continuous manufacturing will help fulfil Grand Challenge 1 and its aim to explore how oral solid dosage medicines can be produced more robustly and efficiently. The contribution by Siemens will also support Grand Challenge 2 and its focus on the faster delivery of medicines to patients through adaptive clinical trial supply.
     
    “We are delighted to be part of such a forward-thinking, innovative collaboration with Perceptive Engineering, PSE and the Medicines Manufacturing Innovation Center,” said Mark Higham, general manager, process automation, Siemens Digital Industries GB & Ireland. “We look forward to unlocking the power of digitalization to achieve continuous improvement and efficiency in pharmaceutical manufacturing in the UK.”
     
    Dave Lovett, managing director, Perceptive Engineering, said, “We are honored to have been asked to play a part in this ground-breaking initiative. Building on our experience with research organizations and industry leaders worldwide, we are excited to be working collaboratively with CPI at the new center. We look forward to helping design and build the next generation of innovative manufacturing technologies for the production of pharmaceutical therapeutics.”
     
    “We are excited to be part of this initiative aimed at publicly demonstrating the benefits that digital design and digital operation approaches bring to the development and operation of continuous drug manufacture processes,” said Sean Bermingham, head of formulated products, PSE. “The Medicines Manufacturing Innovation Center ecosystem is uniquely positioned to successfully achieve this, facilitate knowledge transfer to industry and ultimately bring the associated benefits to patients.”
     
    Dave Tudor, managing director of the Medicines Manufacturing Innovation Center, Biologics & Quality, CPI, said, “I am delighted that Siemens, Perceptive Engineering and PSE will be joining the Medicines Manufacturing Innovation Center. Combining the specialized skills, expertise and experience of all three companies will be critical for developing disruptive technologies that will accelerate the delivery of a more agile and responsive pharmaceutical supply chain.”
    Suggested For You
    Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss
    Lonza Breaks Ground on Commercial Drug Product Facility in Stein Lonza Breaks Ground on Commercial Drug Product Facility in Stein
    EUROAPI Reports Progressive Restart of Prostaglandin Production EUROAPI Reports Progressive Restart of Prostaglandin Production
    Exothera Names Darren Leva as Chief Business Officer Exothera Names Darren Leva as Chief Business Officer
    New CDMO Vector BioMed Launches Operations New CDMO Vector BioMed Launches Operations
    Mikart Invests in New Liquids and Suspensions Suite Mikart Invests in New Liquids and Suspensions Suite
    Pfizer Revenues Soar to Record-Breaking $100B in 2022 Pfizer Revenues Soar to Record-Breaking $100B in 2022
    Lilly to Invest $450M at Manufacturing Site in Research Triangle Park Lilly to Invest $450M at Manufacturing Site in Research Triangle Park
    Lonza Further Invests in Drug Product Manufacturing Capabilities Lonza Further Invests in Drug Product Manufacturing Capabilities
    Rentschler Biopharma to Support Albert Einstein Discovery Center Rentschler Biopharma to Support Albert Einstein Discovery Center
    First Patient is Dosed with Triumvira First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy
    Recro Pharma Signs Renewable Energy Agreement with Georgia Power Recro Pharma Signs Renewable Energy Agreement with Georgia Power
    Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate  Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    CuriRx Launches CuriLytics Platform for Biotherapeutic Development CuriRx Launches CuriLytics Platform for Biotherapeutic Development
    Thermo Fisher Launches Gibco AAV Production System Thermo Fisher Launches Gibco AAV Production System

    Related Breaking News

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss

      Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss

      Novel AAV capsid Anc80 enables efficient gene transfer.
      02.01.23

    • Breaking News | Facilities | Industry News
      Lonza Breaks Ground on Commercial Drug Product Facility in Stein

      Lonza Breaks Ground on Commercial Drug Product Facility in Stein

      Milestone for the development of Lonza’s first large-scale drug product manufacturing facility based in Stein.
      02.01.23

    • Breaking News | cGMP Manufacture | Industry News
      EUROAPI Reports Progressive Restart of Prostaglandin Production

      EUROAPI Reports Progressive Restart of Prostaglandin Production

      Majority of production at the Budapest site expected to be back online by mid-April 2023.
      02.01.23


    • Breaking News | Promotions & Moves
      Exothera Names Darren Leva as Chief Business Officer

      Exothera Names Darren Leva as Chief Business Officer

      Leva brings 20 years of broad commercial expertise to Exothera from a range of experiences with CDMOs, therapeutics, and software companies.
      02.01.23

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      New CDMO Vector BioMed Launches Operations

      New CDMO Vector BioMed Launches Operations

      The biomanufacturing company’s mission is to provide access to high-quality lentiviral vectors and address the vector supply bottleneck.
      02.01.23

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    • Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Natrol Launches First Non-Melatonin Sleep Supplement
    Metagenics Releases Consumer Survey on Menopausal Support Supplement
    Coatings World

    Latest Breaking News From Coatings World

    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    AkzoNobel Shares Sustainable Architectural Solutions at Conference
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Stoelzle Glass Group Names New CEO
    Happi

    Latest Breaking News From Happi

    The Estée Lauder Companies Launches 2023 Breast Cancer Campaign
    BASF Personal Care Introduces New Cosmetic Ingredient
    Breakfast with Oral Care Benefits?
    Ink World

    Latest Breaking News From Ink World

    Siegwerk’s Climate Targets Validated by SBTi
    ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
    Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
    SCHOTT Strengthens Glass Substrate Portfolio

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login